The high cost of radon remediation in the 1980s led to detractors arguing that the issue is a financial boondoggle reminiscent of the swine flu scare of 1976.[112] They further argued that the results of mitigation are inconsistent with lowered cancer risk, especially when indoor radon levels are in the lower range of the actionable exposure level.[112]